Former President Donald Trump's confusion between Tylenol and hydroxychloroquine during the presidential debate triggers a sharp sell-off in pharmaceutical stocks, with Kenvue shares taking a significant hit.
Pharmaceutical giant Kenvue has issued a stern rebuke to Donald Trump after he suggested the COVID-19 vaccine was comparable to the Tylenol murders, calling the analogy 'irresponsible'.
A senior Chinese pharmaceutical executive has been sentenced to 15 years in a US prison for conspiring to manufacture and distribute fentanyl, marking a significant victory in the transatlantic fight against the opioid crisis.
Exclusive analysis reveals how Oracle's mysterious stock movements and a potential TikTok ownership stake could signal a major shift in global tech and create opportunities for savvy investors.
Wall Street and Asian markets rallied as Intel and Nvidia shares soared on AI optimism, while the Bank of Japan maintained its negative interest rates. Get the full analysis on the global market surge.
Exclusive insight into how NHS England's shrewd negotiation tactics secure massive discounts on vital medicines, from cancer treatments to rare disease drugs, ensuring sustainable healthcare funding.
Breakthrough obesity drug Orforglipron shows unprecedented results in clinical trials, reducing body weight by a fifth and offering new hope for millions struggling with weight management in the UK.
Former chief scientific adviser Sir Patrick Vallance warns that dwindling investment in medical research and innovation threatens the future of the NHS and patient care. Discover the urgent call for action.
Pharmaceutical giant Merck to manufacture flagship cancer drug Lynparza at new €1 billion Irish facility, dealing significant blow to UK's life sciences sector and raising fresh post-Brexit trade concerns.
Exclusive analysis reveals how a potential Trump presidency could jeopardise Britain's NHS medicine pricing, forcing UK patients to pay US-style pharmaceutical costs.
Major pharmaceutical giants AstraZeneca, MSD (Merck), and Eli Lilly announce massive new investments in UK research and manufacturing, signalling a major vote of confidence in the British life sciences sector following the US election result.
Tesla faces a staggering $50bn market valuation loss as shareholders reject Elon Musk's colossal $56bn pay package, triggering a dramatic share price collapse and raising serious corporate governance concerns.
Pharmaceutical giant AstraZeneca has paused plans for its new £500 million global headquarters in Cambridge, citing an 'unfavourable' UK economic climate and sending shockwaves through the business community.
Groundbreaking research uncovers a disturbing correlation between widely prescribed drugs, including beta-blockers and anti-anxiety medications, and a sharp increase in suicide risks and depression in children and young adults. Experts are calling for urg
Pharmaceutical giant AstraZeneca pauses its major £200m Cambridge research centre expansion, citing global strategic review and UK economic uncertainty in post-Brexit landscape.
Sanofi executive warns of UK's worsening medicines access crisis, citing post-Brexit regulations, NICE hurdles, and a pricing system that deters investment and innovation.
Pharmaceutical giant MSD, known as Merck in the US, is significantly expanding its UK presence with a new state-of-the-art research hub in London, generating over 125 new high-skilled jobs and reinforcing the city's status as a global life sciences leader
Trainline's stock value nosedived after the Labour Party's election victory, with plans to create a new state-owned ticketing operator sending shockwaves through the transport sector.
The London Stock Exchange faced a sharp sell-off on Thursday, with the FTSE 100 dragged down by a global tech rout and disappointing corporate earnings. Key figures like Elon Musk face scrutiny.
Exclusive report reveals Donald Trump pressured US health officials to accelerate vaccine approval for political gain ahead of the 2020 election, according to congressional investigation.
Exclusive: Diabetes and weight loss patients face financial strain as Eli Lilly's new Mounjaro KwikPens hit the market without the anticipated price reduction, maintaining a premium cost for the identical medication.
A tense US Congressional hearing investigates a surge in severe neurological illnesses in children following vaccination, as lawmakers demand answers from pharmaceutical executives.
Danish pharmaceutical giant Novo Nordisk's market value skyrockets past £400bn, briefly eclipsing the entire Danish economy, on the back of soaring demand for its blockbuster weight-loss drug, Wegovy.
German authorities have confiscated thousands of doses of the in-demand weight-loss medication Wegovy from a Frankfurt wholesaler, citing illegal parallel imports from outside the EU and improper storage conditions.
A 13-year-old girl from Northern Ireland tragically passed away just days after being prescribed a new asthma medication. Her devastated family is now demanding answers from health authorities.
Groundbreaking medical research reveals a new anti-inflammatory drug shows no significant advantage over traditional aspirin for heart attack prevention in most patients, challenging pharmaceutical expectations.
In a landmark move for public health, California, Oregon, and Washington announce a unified 'West Coast Pact' to independently review COVID-19 vaccines, prioritising safety and science over political pressure.
The FTSE 100 surged on Wednesday, propelled by strong performances from Rolls-Royce and Ocado. Discover the key drivers behind the rally and what it means for investors.
The CEO of Pfizer has alleged that former President Donald Trump directly suggested he should be awarded a Nobel Prize for his role in the rapid development of the COVID-19 vaccine, a revelation that has sent shockwaves through political and scientific ci
Podcast titan Joe Rogan ignites a fierce debate by citing controversial research connecting widely prescribed antidepressants to the epidemic of mass shootings. This investigation delves into the science and the silenced studies.